Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, predicts the future of the learning health system in the United States.
Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, predicts the future of the learning health system in the United States.
Transcript
Do you see the trappings of a real, learning health system taking place in the United States? How much further do we have to go before it is fully functioning?
In 2007, the Institute of Medicine came out and called for the establishment of the learning healthcare system. The notion that we can improve patient outcomes from learning from every single patient.
Now we’re 10 years later and I think that what we’ve learned is that before we can have this learning healthcare system we really need a learning healthcare platform and that’s really a challenging data problem. Particularly so in oncology. You need to take in and bring together structured [electronic health record] data, curated data from unstructured notes and even additional data sources altogether into this consistent overarching data representation. Then do that on a national scale. Connecting community oncologists across the country on a common platform and so this all takes time.
We’re in the early innings, but we’re getting there.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More